Indefinite Delivery Contract W81K0225DA010
Award Date 10/1/25
Last Date to Order 9/30/30
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed Similar IDVs
- Biofire Defense LLC has been awarded an Other Transaction Agreement for Prototype valued at $20.97 million by the Joint PEO Chemical and Biological Defense, a defense agency organization, effective July 1, 2024. This IDV was awarded competitively without a set-aside designation and establishes a vehicle for the development and delivery of an FDA-cleared, reusable, adaptable diagnostic device designed to analyze biological warfare agents and infectious disease agents in human clinical...
- This is a Blanket Purchase Agreement (BPA) awarded by the U.S. Department of Defense's Medical Command to Biofire Defense LLC, a for-profit limited liability company based in Utah. The BPA is valued at $644,934.25 and has a period of performance from June 5, 2018 to June 11, 2023. It is a single-award contract with no set-asides used. The purpose of this BPA is to provide the Medical Command with various reagent kits and diagnostic panels for the Biofire FilmArray system platforms, including...
- The Indefinite Delivery Contract awarded by the Department of the Air Force Air Combat Command is a single award contract to Biofire Defense LLC for Biofire test kits and reagents. With a potential value of $1.7 million and a period of performance through July 2028, the contract enables the 99th Medical Group to issue delivery orders for diagnostic products over the next five years in support of their biological detection operations. No set-aside was used for this SBIR Phase III contract action....
- Biofire Defense LLC, a for-profit limited liability company based in Salt Lake City, Utah, has been awarded a $500,000 Multiple Award Schedule (MAS) contract by the General Services Administration (GSA) to provide biological agent identification and infectious disease diagnostic products and services to federal agencies. Under this MAS contract, Biofire Defense will deliver a range of diagnostic solutions, including the Biofire FilmArray and RAZOR Mk II systems, as well as in-vitro diagnostic...
- Biofire Defense LLC was awarded an Other Transaction Agreement for Prototype by the Department of the Army with a ceiling value of $8.3 million, effective August 1, 2025, with no set-aside designation applied. This agreement funds a validation effort for the Environmental Film Array Next Generation Diagnostic System (NGDS) Sentinel Panel, designed for integration with the Biofire Spotfire system. The contractor will conduct prototype testing and validation activities to establish the technical...
- The Department of State Bureau of Administration awarded a single award indefinite delivery contract to Biofire Defense LLC with a potential value of $600,000. The contract aims to procure Biofire products to support the Department's biological detection and analysis programs. The contract includes four firm fixed price delivery orders placed with Biofire Defense LLC totaling $332,936 for diagnostic consumables. The delivery orders require Biofire to provide Biofire consumables from their...
- This indefinite delivery contract is awarded by the Bureau of Administration, a civilian federal agency, to Biofire Defense LLC, a for-profit limited liability company and manufacturer of biological agent identification products. The $740,000 IDIQ contract has a period of performance through August 31, 2025 and is for the provision of testing kits and related consumables to support the agency's biodefense and infectious disease diagnostics needs. Several delivery orders have been issued under...
- The U.S. Department of Defense's Joint Program Executive Office for Chemical and Biological Defense (JPEO-CBD) awarded an Indefinite Delivery Contract (IDC) to Biofire Defense LLC, a for-profit limited liability company that manufactures biological agent identification products. The contract, valued at up to $18.8 million through January 2029, is for the sustainment of the Next Generation Diagnostic System (NGDS) 1. Under this IDC, JPEO-CBD has issued several firm-fixed-price and...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 awarded a blanket purchase agreement to Biofire Diagnostics LLC for molecular pathogen detection services. Biofire will provide products and services to support VHA programs such as COVID-19 testing, diagnostic testing, and infectious disease screening. Performance locations include Utah, Florida, and other states. Estimated values range from $30k to over $1.5M for individual task orders, with...
- This Indefinite Delivery Contract (IDC) with the National Institutes of Health (NIH) Clinical Center was awarded to Biofire Defense LLC, a for-profit limited liability company that manufactures biological threat detection and infectious disease diagnostic products. The $1,654,215.94 IDC, awarded on January 8, 2025 with a completion date of September 30, 2025, is for the procurement of Biofire reagents. Based on Biofire Defense's past contract awards, this IDC may include the delivery of...
Name | Description | Awardee | Potential Value | AwardDate | CompletionDate | Updated At |
|---|---|---|---|---|---|---|
Delivery Order W81K0225DA010-W81K0225FA133 | Biofire Defense LLC | $968.3k | 10/1/25 | 9/30/26 | 9/11/25 |